Antibody Internalization - China

Efficient antibody internalization is a key factor in successful ADC development Antibodies specific to cell surface antigens can induce endocytosis, leading to the internalization of the antibodies along with any molecules conjugated to them.

This process, termed Antibody Internalization (ABI), has powerful applications in both research and clinical discovery, including: ● Delivery of highly toxic drugs to specific cancer cells via antibody-drug conjugates (ADCs) ● Removal or degradation of surface receptors from cancer cells (e.g., EGFR) ● Antibody immunotherapies that identify tumor cells for immune cell-mediated killing (e.g., ADCC or ADCP) Antibody Internalization Assay Detection Reagent AlpVHHs offers a series of VHH (nanobody)-based nano-secondary products specifically designed for evaluating antibody internalization efficiency during the early stage of ADC drug development.

This series is particularly suitable for: ● High-throughput screening of antibody internalization efficiency prior to ADC construction ● Rapid functional evaluation and comparison of multiple antibody candidates ● Early-stage ADC drugability assessment in cell-based systems All products are based on VHH nano-secondary technology, ensuring consistent secondary recognition and reliable assay performance, making them ideal tools for ADC pre-screening workflows.

Designed for ADC Pre-Development Screening Before investing in ADC synthesis, it is critical to determine whether candidate antibodies possess sufficient internalization capability.

The AlpVHHs Nano-secondary series enables: ● Functional evaluation of antibody internalization ● Rapid comparison of multiple antibody candidates ● High-throughput screening in cell-based systems ● Early-stage ADC drugability assessment Accelerate your antibody-drug conjugate (ADC) research with AlpVHHs' advanced nanobody-based tools.

Our Nano-Secondary ADCs, Nano-DT detection kits, and pH-sensitive probes provide precise, high-throughput internalization detection for both human and mouse antibodies.

Optimize your workflow with low-background, high-specificity reagents trusted by leading biotech and pharmaceutical partners worldwide.

Company Contact:

• Posted By: AlpVHHs

• Phone: 138 8067 6215

• Address: Building 16, No.99 Haiwang Road, Wenjiang District, Chengdu, China 611130, chengdu , chengdu , China

• Email:

• Website: https://www.alpvhhs.com/

• Business Description: A specialized nanobody (VHH) discovery platform and antibody pre-discovery CRO service provider, offering high-affinity nanobody products and custom VHH solutions.